Stocks Health care MDWD
NASDAQ · Health careMediWound Ltd. (MDWD)
MediWound Ltd. reported revenue of $17M in fiscal 2025, down 16.1% from a year earlier. It posted a net loss of $23.9M. In fiscal 2025 capital spending exceeded operating cash flow by $21.6M. At December 31, 2025 it held $4.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
Key facts about MediWound Ltd.
- Net worth
- MediWound Ltd. has a market value (market cap) of $181.8M at the latest share price, and shareholders' equity of $43.6M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $17M (-16.1% year on year), with a net loss of $23.9M.
- Cash flow
- In fiscal 2025 operations used $16.1M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 5, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What MediWound Ltd. does
MediWound Ltd. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker MDWD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $17M | -$23.9M | -$2.10 | -$21.6M |
| 2024 | $20.2M | -$30.2M | -$3.03 | -$19.9M |
| 2023 | $18.7M | -$6.7M | -$0.75 | -$16.9M |
| 2022 | $26.5M | -$19.6M | -$3.93 | -$12.4M |
| 2021 | $23.8M | -$13.6M | -$3.48 | -$9.4M |
| 2020 | $21.8M | -$9.2M | -$2.38 | -$7.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MDWD ranks in Health care
Latest SEC filings
What MediWound Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- August 28, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- May 27, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 6, 2026
- April 2, 2026
- March 30, 2026
- March 5, 2026
Insider trades
What the people running MediWound Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $6.6K and sold $82.1K worth of shares in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 1, 2026 | Rubinstein SamuelDirector | Soldindirect | 525 | $6.7K |
| September 1, 2026 | Rubinstein SamuelDirector | Boughtindirect | 525 | $6.6K |
| August 27, 2026 | Hess ShmuelCOO & Chief Commercial Officer | Sold | 1,979 | $25.2K |
| August 27, 2026 | Hess ShmuelCOO & Chief Commercial Officer | Sold | 1,979 | $26K |
| August 26, 2026 | Hess ShmuelCOO & Chief Commercial Officer | Sold | 1,865 | $24.2K |
| June 3, 2026 | Shamir NachumDirector | Bought | 175 | $2.4K |
| June 3, 2026 | Shamir NachumDirector | Bought | 5,825 | $81.6K |
| June 1, 2026 | Fox David MortonDirector | Bought | 1,730 | $24.6K |
Who owns MDWD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Access Industries Holdings LLC13D, may seek influence with 6 related filers | 11.56% | October 3, 2025 |
| HOLD Alapkezelo Zrt.13G, passive | 10.4% | August 28, 2026 |
| Mölnlycke Health Care AB13D, may seek influence with 6 related filers | 8.1% | July 19, 2024 |
| Rosalind Advisors, Inc.13G, passive with 3 related filers | 7% | February 11, 2026 |
| Yelin Lapidot Holdings Management Ltd.13G, passive with 2 related filers | 5.95% | February 5, 2026 |
| T. Rowe Price Associates, Inc.13G, passive | 5% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 79 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Investor AB | 872,093 | 0 |
| Yelin Lapidot Holdings Management Ltd. | 758,169 | -4,648 |
| Rosalind Advisors, Inc. | 749,054 | 0 |
| BlackRock, Inc. | 525,929 | +80,095 |
| Sphera Funds Management Ltd. | 273,192 | 0 |
| Silverberg Bernstein Capital Management LLC | 228,137 | +28,132 |
| State Street Corp | 168,669 | +24,899 |
| UBS Group AG | 155,922 | -3,869 |
| Geode Capital Management, LLC | 141,041 | +19,083 |
| Point72 Asset Management, L.P. | 129,248 | -46,231 |
| ARK Investment Management LLC | 126,576 | -3,385 |
| Northern Trust Corp | 112,191 | -9,585 |
| DAFNA Capital Management LLC | 94,405 | 0 |
| Morgan Stanley | 88,660 | +187 |
| Vanguard Portfolio Management LLC | 70,143 | +12,596 |
| Sargent Investment Group, LLC | 62,481 | +3,000 |
| Citadel Advisors LLC | 58,496 | -744 |
| Aqr Capital Management LLC | 50,357 | new |
| Summit Financial, LLC | 46,914 | -357 |
| Phoenix Financial Ltd. | 39,000 | new |
Insiders
3 insiders reported holding 81,616 shares in total, about $1.1M at the last price.
| Holder | Shares |
|---|---|
| Shamir NachumDirector | 55,815 |
| Fox David MortonDirector | 22,283 |
| Rubinstein SamuelDirector | 3,518525 held indirectly |
Questions about MDWD
What does MediWound Ltd. do?
MediWound Ltd. is a company in the Health care sector, listed on NASDAQ as MDWD. Its shares trade on NASDAQ under the ticker MDWD.
What is MediWound Ltd.'s net worth?
MediWound Ltd. has a market value (market cap) of $181.8M at the latest share price, and shareholders' equity of $43.6M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is MediWound Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $23.9M on revenue of $17M.
How much revenue does MediWound Ltd. make?
In fiscal 2025 MediWound Ltd. reported revenue of $17M. That is 16.1% less than a year earlier.
When did MediWound Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from November 5, 2026.
Similar companies
Compare MDWD with
Follow MDWD
Get an email when MediWound Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values MediWound Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.